Searche

Your search for "medical writers" matched 427 page(s).

Showing results 391 to 400.

Outgoing President's Message - Volume 33, Issue

Time flies – nothing new in that then! The year of my presidency is finished, so it is time to look back and summarise. It was my first task as a president to introduce a 5-year strategic plan for 2023–2027, and together with the whole Executive…

How can real-world data, registries, and databases address the challenges of rare diseases? - Volume 34, Issue

A goal for all diseases is a treatment that works to prevent, halt, or reverse their effects – essentially, a cure. Achieving this requires early diagnosis, knowledge of disease mechanisms, and effective treatment. For rare diseases, each of these…

An interview with Research Policy and Initiatives Director Roseline Favresse at the European Organisation for Rare Diseases - Volume 34, Issue

Roseline Favresse is the Research Policy and Initiatives Director at the European Organisation for Rare Diseases (EURORDIS). We interviewed Roseline to learn more about the rare disease landscape within Europe and the exciting recent collaborations…

Celebrating its past, European Medicines Agency looks to the future of public communication - Volume 34, Issue

As the European Medicines Agency (EMA) marks its 30th anniversary with a series of events at its offices in Amsterdam, one area in the spotlight is EMA’s communication with the public. The Agency has made significant strides in this area over the…

Harnessing landing pages for effective patient enrolment in clinical trials - Volume 34, Issue

This article highlights that patient-centric landing pages offer a powerful and effective solution to the persistent challenges of clinical trial enrolment. Besides, implementing these strategies can also bridge the awareness gap and accelerate…

Introducing EMWA’s new AI Working Group - Volume 32, Issue

Artificial Intelligence (AI) is a broad umbrella term that refers to the use of computer algorithms to perform tasks that typically require human-like intelligence, such as reasoning, learning, decision-making, and perception. The new EMWA AI…

Getting Your Foot in the Door - Volume 32, Issue

Editorial Ivan Turek (section editor) Medical Writing. 2023;32(3):91. The hitchhiker’s guide to the EMWA conference: Reflections and recommendations from first-time delegates Anna Isermann, Louisa Ludwig-Begall (authors) “The story so far: In…

How remote working can affect mental health: Work-life balance and meeting fatigue - Volume 31, Issue

When it comes to remote working, we often think about the many benefits this approach brings, such as being more flexible and productive, or improving our work-life balance. However, remote working without the right framework to profit from all…

Wait! What? There’s stuff missing from the scholarly record? - Volume 31, Issue

The scholarly record is an ever-evolving network – or graph – of truth assertions on which each discipline bases its discussions, and against which each discipline measures its progress. But what if the scholarly record is missing a significant…

EMA Foreword - Volume 32, Issue

The EU Clinical Trials Regulation and its much-anticipated benefits: Foreword from the European Medicines Agency The year 2022 signalled the beginning of a new way of handling clinical trials in Europe, with the implementation of the EU Clinical…

Visit the EMWA website

Search

Links

The Write Stuff Archive Contact Instructions for Authors Article Template (Word) Journal Policies

Scope

Medical Writing is a quarterly publication that aims to educate and inform medical writers in Europe and beyond. Each issue focuses on a specific theme, and all issues include feature articles and regular columns on topics relevant to the practice of medical writing. We welcome articles providing practical advice to medical writers; guidelines and reviews/summaries/updates of guidelines published elsewhere; original research; opinion pieces; interviews; and review articles.

Medical Writing is listed in the following indexes: